GeneDx Holdings (WGS) EBIAT (2020 - 2025)
Historic EBIAT for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$7.6 million.
- GeneDx Holdings' EBIAT rose 814.49% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 10249.47%. This contributed to the annual value of -$52.3 million for FY2024, which is 7025.27% up from last year.
- Per GeneDx Holdings' latest filing, its EBIAT stood at -$7.6 million for Q3 2025, which was up 814.49% from $10.8 million recorded in Q2 2025.
- Over the past 5 years, GeneDx Holdings' EBIAT peaked at $32.7 million during Q3 2021, and registered a low of -$308.8 million during Q4 2022.
- In the last 5 years, GeneDx Holdings' EBIAT had a median value of -$40.2 million in 2021 and averaged -$54.0 million.
- Per our database at Business Quant, GeneDx Holdings' EBIAT soared by 15781.33% in 2021 and then crashed by 66834.89% in 2022.
- Quarter analysis of 5 years shows GeneDx Holdings' EBIAT stood at -$40.2 million in 2021, then plummeted by 668.35% to -$308.8 million in 2022, then surged by 91.65% to -$25.8 million in 2023, then skyrocketed by 121.1% to $5.4 million in 2024, then plummeted by 240.4% to -$7.6 million in 2025.
- Its EBIAT was -$7.6 million in Q3 2025, compared to $10.8 million in Q2 2025 and -$6.5 million in Q1 2025.